Suchergebnisse
Suchergebnisse:
22nd Century Group, Inc. (Nasdaq: XXII) is a next-generation plant biotechnology company, focused on improving human health through plant science. Using our breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, we have developed the first market-ready, reduced nicotine content (RNC) tobacco plants and ...
22ND CENTURY GROUP AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie 22nd Century Group Inc | A1W2NQ | XXII | US90137F1030
17. Mai 2024 · 22ND CENTURY GROUP AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie 22nd Century Group Inc Registered Shs | A403VQ | XXII | US90137F3010.
13. Mai 2024 · Corporate Overview. 22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding.
About 22nd Century Group. 22nd Century Group, Inc. (Nasdaq: XXII) is a next-generation plant biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving plants to enhance human health. Using our breakthrough, patent-protected IP to control nicotine biosynthesis in the tobacco plant, we have developed the ...
22nd Century Group, Inc. ist ein landwirtschaftliches Biotechnologieunternehmen. Das Unternehmen konzentriert sich auf die Reduzierung von Tabakschäden, nikotinreduzierten Tabak und die Verbesserung von Gesundheit und Wohlbefinden durch Pflanzenwissenschaft. Darüber hinaus bietet das Unternehmen Auftragsfertigungsdienstleistungen für ...
22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine...
